Anti-obesity drugs such as semaglutide (Ozempic, Wegovy) are also promising for the treatment of alcohol use disorder and ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitors ...

Metformin has been prescribed to people with type 2 diabetes to manage blood sugar for more than 60 years, but scientists ...

A specific gene mutation leads to aldehyde storm, an accumulation of aldehyde, which makes the person prone to liver damage ...

New research unveils a groundbreaking quintuple agonist that targets multiple pathways for effective treatment of obesity and ...

A research team has now tested a compound solid beverage formulated from Pu-erh tea extract, catechin, and theanine, finding ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor ...

Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...

Berberine aka Nature’s Ozempic is said to offer a plethora of benefits from aiding in weight loss to lowering blood sugar But ...

A new study by researchers from the University of Texas MD Anderson Cancer Center has revealed that the glucose-fructose mix commonly found in sugary drinks could play a direct role in accelerating ...

Details of a new drug that aims to treat the underlying causes of obesity are being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...

Details of a new drug that aims to treat the underlying causes of obesity are being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...